LLY logo

Eli Lilly and Company (LLY) Cash from financing

annual CFF:

$1.23B-$2.27B(-64.81%)
December 31, 2024

Summary

  • As of today (May 29, 2025), LLY annual cash flow from financing activities is $1.23 billion, with the most recent change of -$2.27 billion (-64.81%) on December 31, 2024.
  • During the last 3 years, LLY annual CFF has risen by +$5.36 billion (+129.78%).
  • LLY annual CFF is now -64.81% below its all-time high of $3.50 billion, reached on December 31, 2023.

Performance

LLY Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYcash flow metrics

quarterly CFF:

$1.38B+$1.61B(+712.11%)
March 31, 2025

Summary

  • As of today (May 29, 2025), LLY quarterly cash flow from financing activities is $1.38 billion, with the most recent change of +$1.61 billion (+712.11%) on March 31, 2025.
  • Over the past year, LLY quarterly CFF has increased by +$1.69 billion (+543.21%).
  • LLY quarterly CFF is now -67.89% below its all-time high of $4.30 billion, reached on December 31, 2008.

Performance

LLY quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYcash flow metrics

TTM CFF:

$2.92B+$1.69B(+137.47%)
March 31, 2025

Summary

  • As of today (May 29, 2025), LLY TTM cash flow from financing activities is $2.92 billion, with the most recent change of +$1.69 billion (+137.47%) on March 31, 2025.
  • Over the past year, LLY TTM CFF has increased by +$149.10 million (+5.38%).
  • LLY TTM CFF is now -45.51% below its all-time high of $5.36 billion, reached on June 30, 2024.

Performance

LLY TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

LLY Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-64.8%+543.2%+5.4%
3 y3 years+129.8%+147.9%+149.1%
5 y5 years+152.9%+1193.1%+181.5%

LLY Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-64.8%+122.8%-61.1%+147.9%-45.5%+149.1%
5 y5-year-64.8%+122.8%-61.1%+147.9%-45.5%+149.1%
alltimeall time-64.8%+120.8%-67.9%+135.7%-45.5%+149.1%

LLY Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.38B(-712.1%)
$2.92B(+137.5%)
Dec 2024
$1.23B(-64.8%)
-$225.40M(-206.7%)
$1.23B(-75.4%)
Sep 2024
-
$211.30M(-86.4%)
$5.00B(-6.7%)
Jun 2024
-
$1.56B(-599.7%)
$5.36B(+93.4%)
Mar 2024
-
-$311.30M(-108.8%)
$2.77B(-20.7%)
Dec 2023
$3.50B(-164.7%)
$3.54B(+519.7%)
$3.50B(-393.6%)
Sep 2023
-
$572.00M(-155.4%)
-$1.19B(-60.7%)
Jun 2023
-
-$1.03B(-350.6%)
-$3.03B(+43.0%)
Mar 2023
-
$412.30M(-136.1%)
-$2.12B(-60.9%)
Dec 2022
-$5.41B(+30.9%)
-$1.14B(-9.6%)
-$5.41B(-6.6%)
Sep 2022
-
-$1.26B(+921.3%)
-$5.79B(+16.0%)
Jun 2022
-
-$123.70M(-95.7%)
-$4.99B(-16.1%)
Mar 2022
-
-$2.88B(+88.6%)
-$5.95B(+44.1%)
Dec 2021
-$4.13B(+31.7%)
-$1.53B(+229.6%)
-$4.13B(+6.0%)
Sep 2021
-
-$463.20M(-57.2%)
-$3.90B(+5.0%)
Jun 2021
-
-$1.08B(+2.3%)
-$3.71B(-13.7%)
Mar 2021
-
-$1.06B(-18.0%)
-$4.30B(+37.1%)
Dec 2020
-$3.14B(+35.0%)
-$1.29B(+362.7%)
-$3.14B(+6.0%)
Sep 2020
-
-$279.10M(-83.3%)
-$2.96B(-32.3%)
Jun 2020
-
-$1.67B(-1668.1%)
-$4.37B(+22.0%)
Mar 2020
-
$106.70M(-109.6%)
-$3.59B(+54.3%)
Dec 2019
-$2.32B(-60.6%)
-$1.11B(-34.2%)
-$2.32B(-18.5%)
Sep 2019
-
-$1.69B(+91.1%)
-$2.85B(+293.2%)
Jun 2019
-
-$885.80M(-164.8%)
-$725.00M(+8.1%)
Mar 2019
-
$1.37B(-183.4%)
-$670.60M(-88.6%)
Dec 2018
-$5.90B(-4240.9%)
-$1.64B(-478.9%)
-$5.90B(+22.8%)
Sep 2018
-
$432.70M(-152.0%)
-$4.81B(+1.4%)
Jun 2018
-
-$831.40M(-78.5%)
-$4.74B(+66.4%)
Mar 2018
-
-$3.87B(+613.0%)
-$2.85B(-2097.3%)
Dec 2017
$142.60M(-125.5%)
-$542.30M(-208.3%)
$142.60M(-86.7%)
Sep 2017
-
$500.70M(-52.8%)
$1.07B(-3585.7%)
Jun 2017
-
$1.06B(-221.0%)
-$30.70M(-94.0%)
Mar 2017
-
-$875.70M(-327.3%)
-$511.30M(-8.7%)
Dec 2016
-$559.80M(-82.0%)
$385.20M(-164.2%)
-$559.80M(-69.2%)
Sep 2016
-
-$600.10M(-203.6%)
-$1.82B(+0.3%)
Jun 2016
-
$579.30M(-162.7%)
-$1.81B(-45.7%)
Mar 2016
-
-$924.20M(+6.1%)
-$3.33B(+7.2%)
Dec 2015
-$3.11B(+1769.6%)
-$871.40M(+46.4%)
-$3.11B(+342.8%)
Sep 2015
-
-$595.20M(-36.9%)
-$702.50M(+36.9%)
Jun 2015
-
-$943.20M(+34.5%)
-$513.20M(+88.3%)
Mar 2015
-
-$701.20M(-145.6%)
-$272.50M(+63.8%)
Dec 2014
-$166.40M(-95.7%)
$1.54B(-478.7%)
-$166.40M(-93.9%)
Sep 2014
-
-$405.90M(-42.2%)
-$2.74B(-4.3%)
Jun 2014
-
-$702.50M(+18.0%)
-$2.86B(+6.3%)
Mar 2014
-
-$595.10M(-42.6%)
-$2.69B(-29.6%)
Dec 2013
-$3.83B(-13.4%)
-$1.04B(+95.9%)
-$3.83B(-5.6%)
Sep 2013
-
-$529.00M(-0.9%)
-$4.06B(-0.4%)
Jun 2013
-
-$533.80M(-69.1%)
-$4.07B(-0.5%)
Mar 2013
-
-$1.73B(+36.7%)
-$4.09B(-7.4%)
Dec 2012
-$4.42B(+86.5%)
-$1.27B(+132.3%)
-$4.42B(+16.1%)
Sep 2012
-
-$544.70M(-1.4%)
-$3.81B(+2.8%)
Jun 2012
-
-$552.70M(-73.1%)
-$3.70B(-0.3%)
Mar 2012
-
-$2.06B(+216.0%)
-$3.71B(+56.7%)
Dec 2011
-$2.37B(+17.2%)
-$650.90M(+47.6%)
-$2.37B(+4.5%)
Sep 2011
-
-$440.90M(-21.9%)
-$2.27B(+2.1%)
Jun 2011
-
-$564.30M(-20.9%)
-$2.22B(+1.5%)
Mar 2011
-
-$713.80M(+29.9%)
-$2.19B(+8.2%)
Dec 2010
-$2.02B(-63.5%)
-$549.60M(+39.6%)
-$2.02B(-22.3%)
Sep 2010
-
-$393.80M(-25.9%)
-$2.60B(-16.6%)
Jun 2010
-
-$531.50M(-2.8%)
-$3.12B(-15.7%)
Mar 2010
-
-$547.00M(-51.5%)
-$3.70B(-33.1%)
Dec 2009
-$5.53B(-335.9%)
-$1.13B(+23.6%)
-$5.53B(+5023.8%)
Sep 2009
-
-$913.20M(-17.8%)
-$108.00M(-145.1%)
Jun 2009
-
-$1.11B(-53.3%)
$239.40M(-71.1%)
Mar 2009
-
-$2.38B(-155.4%)
$827.50M(-64.7%)
Dec 2008
$2.35B(-377.7%)
$4.30B(-859.5%)
$2.35B(-196.1%)
Sep 2008
-
-$565.80M(+8.1%)
-$2.44B(-0.3%)
Jun 2008
-
-$523.50M(-39.3%)
-$2.45B(-7.6%)
Mar 2008
-
-$861.90M(+75.6%)
-$2.65B(+213.7%)
Dec 2007
-$844.90M
-$490.70M(-14.4%)
-$844.90M(-56.9%)
Sep 2007
-
-$573.20M(-20.9%)
-$1.96B(-40.5%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$724.60M(-176.8%)
-$3.29B(+9.9%)
Mar 2007
-
$943.60M(-158.8%)
-$2.99B(-34.6%)
Dec 2006
-$4.58B(+143.5%)
-$1.60B(-15.8%)
-$4.58B(+22.9%)
Sep 2006
-
-$1.91B(+345.9%)
-$3.73B(+1212.1%)
Jun 2006
-
-$427.50M(-33.2%)
-$284.00M(+20.5%)
Mar 2006
-
-$640.30M(-14.9%)
-$235.70M(-87.5%)
Dec 2005
-$1.88B(-1023.2%)
-$752.60M(-149.0%)
-$1.88B(+63.5%)
Sep 2005
-
$1.54B(-505.2%)
-$1.15B(-44.9%)
Jun 2005
-
-$379.20M(-83.4%)
-$2.09B(-0.6%)
Mar 2005
-
-$2.29B(>+9900.0%)
-$2.10B(-1130.9%)
Dec 2004
$203.70M(-112.9%)
-$22.30M(-103.7%)
$203.70M(-153.0%)
Sep 2004
-
$600.00M(-252.9%)
-$384.00M(-63.5%)
Jun 2004
-
-$392.50M(-2221.6%)
-$1.05B(-13.4%)
Mar 2004
-
$18.50M(-103.0%)
-$1.22B(-22.9%)
Dec 2003
-$1.58B(+274.0%)
-$610.00M(+781.5%)
-$1.58B(-11.8%)
Sep 2003
-
-$69.20M(-87.6%)
-$1.79B(+75.8%)
Jun 2003
-
-$556.00M(+62.1%)
-$1.02B(+14.6%)
Mar 2003
-
-$343.10M(-58.2%)
-$888.60M(+110.6%)
Dec 2002
-$422.00M(-59.8%)
-$820.70M(-216.9%)
-$422.00M(+300.0%)
Sep 2002
-
$701.90M(-264.5%)
-$105.50M(-89.3%)
Jun 2002
-
-$426.70M(-445.5%)
-$986.60M(+55.7%)
Mar 2002
-
$123.50M(-124.5%)
-$633.80M(-39.6%)
Dec 2001
-$1.05B(-53.0%)
-$504.20M(+181.4%)
-$1.05B(-3.3%)
Sep 2001
-
-$179.20M(+142.5%)
-$1.08B(-25.2%)
Jun 2001
-
-$73.90M(-74.6%)
-$1.45B(-21.6%)
Mar 2001
-
-$291.40M(-46.0%)
-$1.85B(-17.1%)
Dec 2000
-$2.23B(+53.5%)
-$539.50M(-0.8%)
-$2.23B(+9.9%)
Sep 2000
-
-$543.90M(+15.1%)
-$2.03B(+71.1%)
Jun 2000
-
-$472.40M(-29.9%)
-$1.19B(-26.1%)
Mar 2000
-
-$673.70M(+99.3%)
-$1.60B(+10.4%)
Dec 1999
-$1.45B(-48.4%)
-$338.00M(-213.2%)
-$1.45B(-31.3%)
Sep 1999
-
$298.60M(-133.5%)
-$2.11B(-26.7%)
Jun 1999
-
-$890.70M(+70.4%)
-$2.88B(+8.6%)
Mar 1999
-
-$522.60M(-47.7%)
-$2.66B(-5.6%)
Dec 1998
-$2.81B(+43.9%)
-$999.20M(+112.0%)
-$2.81B(+37.1%)
Sep 1998
-
-$471.40M(-28.9%)
-$2.05B(-13.1%)
Jun 1998
-
-$662.60M(-2.5%)
-$2.36B(-9.6%)
Mar 1998
-
-$679.50M(+186.2%)
-$2.61B(+33.6%)
Dec 1997
-$1.95B(+17.7%)
-$237.40M(-69.6%)
-$1.95B(-11.7%)
Sep 1997
-
-$781.30M(-14.5%)
-$2.21B(+1.9%)
Jun 1997
-
-$913.50M(+3978.1%)
-$2.17B(+36.0%)
Mar 1997
-
-$22.40M(-95.5%)
-$1.60B(-3.8%)
Dec 1996
-$1.66B(+104.1%)
-$496.50M(-32.9%)
-$1.66B(+1.5%)
Sep 1996
-
-$739.50M(+118.2%)
-$1.64B(+38.6%)
Jun 1996
-
-$338.90M(+293.2%)
-$1.18B(+8.6%)
Mar 1996
-
-$86.20M(-81.7%)
-$1.09B(+33.7%)
Dec 1995
-$813.70M(-128.7%)
-$472.30M(+66.5%)
-$813.70M(-132.4%)
Sep 1995
-
-$283.60M(+15.4%)
$2.51B(-5.9%)
Jun 1995
-
-$245.80M(-230.7%)
$2.67B(-9.3%)
Mar 1995
-
$188.00M(-93.4%)
$2.94B(+3.8%)
Dec 1994
$2.84B(-642.4%)
$2.86B(-2348.6%)
$2.84B(-1297.2%)
Sep 1994
-
-$127.00M(-563.5%)
-$237.00M(-38.0%)
Jun 1994
-
$27.40M(-66.3%)
-$382.20M(-41.6%)
Mar 1994
-
$81.20M(-137.1%)
-$654.10M(+25.0%)
Dec 1993
-$523.10M(-11.1%)
-$218.60M(-19.7%)
-$523.10M(-33.6%)
Sep 1993
-
-$272.20M(+11.3%)
-$788.20M(+55.9%)
Jun 1993
-
-$244.50M(-215.2%)
-$505.70M(+55.4%)
Mar 1993
-
$212.20M(-143.9%)
-$325.40M(-44.7%)
Dec 1992
-$588.60M(+111.6%)
-$483.70M(-4796.1%)
-$588.60M(+97.8%)
Sep 1992
-
$10.30M(-116.0%)
-$297.60M(-40.6%)
Jun 1992
-
-$64.20M(+25.9%)
-$500.90M(+46.7%)
Mar 1992
-
-$51.00M(-73.5%)
-$341.40M(+22.7%)
Dec 1991
-$278.20M(-29.3%)
-$192.70M(-0.2%)
-$278.20M(+25.1%)
Sep 1991
-
-$193.00M(-302.5%)
-$222.30M(+40.3%)
Jun 1991
-
$95.30M(+681.1%)
-$158.50M(-52.6%)
Mar 1991
-
$12.20M(-108.9%)
-$334.70M(-15.0%)
Dec 1990
-$393.70M(-26.7%)
-$136.80M(+5.9%)
-$393.70M(+53.3%)
Sep 1990
-
-$129.20M(+59.7%)
-$256.90M(+101.2%)
Jun 1990
-
-$80.90M(+72.9%)
-$127.70M(+172.9%)
Mar 1990
-
-$46.80M
-$46.80M
Dec 1989
-$537.00M
-
-

FAQ

  • What is Eli Lilly and Company annual cash flow from financing activities?
  • What is the all time high annual CFF for Eli Lilly and Company?
  • What is Eli Lilly and Company annual CFF year-on-year change?
  • What is Eli Lilly and Company quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly CFF year-on-year change?
  • What is Eli Lilly and Company TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM CFF year-on-year change?

What is Eli Lilly and Company annual cash flow from financing activities?

The current annual CFF of LLY is $1.23B

What is the all time high annual CFF for Eli Lilly and Company?

Eli Lilly and Company all-time high annual cash flow from financing activities is $3.50B

What is Eli Lilly and Company annual CFF year-on-year change?

Over the past year, LLY annual cash flow from financing activities has changed by -$2.27B (-64.81%)

What is Eli Lilly and Company quarterly cash flow from financing activities?

The current quarterly CFF of LLY is $1.38B

What is the all time high quarterly CFF for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly cash flow from financing activities is $4.30B

What is Eli Lilly and Company quarterly CFF year-on-year change?

Over the past year, LLY quarterly cash flow from financing activities has changed by +$1.69B (+543.21%)

What is Eli Lilly and Company TTM cash flow from financing activities?

The current TTM CFF of LLY is $2.92B

What is the all time high TTM CFF for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM cash flow from financing activities is $5.36B

What is Eli Lilly and Company TTM CFF year-on-year change?

Over the past year, LLY TTM cash flow from financing activities has changed by +$149.10M (+5.38%)
On this page